Vanillic Acid / GSK‐3β Cancer Research Results

VA, Vanillic Acid: Click to Expand ⟱
Features:

Vanillic Acid - 4-Hydroxy-3-Methoxybenzoic Acid

Type: Phenolic acid / hydroxybenzoic acid derivative

Sources: Vanillic acid occurs naturally in numerous plants and foods and is also produced through metabolism of other phenolic compounds including vanillin and ferulic-acid-related compounds.

Function: Vanillic acid is a naturally occurring phenolic acid with antioxidant, anti-inflammatory, metabolic, and antiproliferative activities. It can influence oxidative stress, mitochondrial function, apoptosis, cell-cycle regulation, inflammatory signaling, and pathways including NF-κB, PI3K/AKT/mTOR, JAK/STAT, and MAPK signaling.

Cancer: Preclinical studies demonstrate antiproliferative, pro-apoptotic, anti-invasive, anti-migratory, and anti-angiogenic effects. Reported mechanisms include inhibition of NF-κB, PI3K/AKT/mTOR and JAK/STAT signaling, reduction of VEGF, MMP-2 and MMP-9, cell-cycle arrest, and modulation of mitochondrial apoptosis and oxidative stress. Clinical anticancer efficacy has not been established.

Alzheimer's Disease: Preliminary and indirect evidence suggests potential neuroprotective relevance through antioxidant, anti-inflammatory, mitochondrial, and anti-apoptotic mechanisms. Vanillic acid occurs among bioactive constituents of medicinal plants investigated in Alzheimer's disease models, but direct evidence for vanillic acid as an Alzheimer's treatment remains limited.
GSK‐3β, Glycogen synthase kinase (GSK)3β: Click to Expand ⟱
Source:
Type:
GSK3β is a crucial member of the Wnt/β-catenin-, hedgehog (Hh)-, notch- and c-myc-mediated major pro-oncogenic pathways, while also being a negative regulator of epithelial–mesenchymal transition (EMT). Accumulating evidence defines GSK3β as a potential therapeutic target in cancer, thus encouraging the development of GSK3β inhibitors for cancer treatment.
Glycogen synthase kinase 3 beta (GSK-3β) is a serine/threonine kinase that plays a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Its expression and activity have been implicated in several types of cancer, often with varying prognostic implications.

In many cancers, decreased GSK-3β activity is associated with poor prognosis, while in others, increased activity may correlate with aggressive disease.


Scientific Papers found: Click to Expand⟱
7834- VA,  MBS,    Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review
- Review, AD, NA
*neuroP↑, *memory↑, *Learn↑, *Aβ↓, *BACE/β-secretase↓, *NeuroI↓, *RAGE↓, *antiOx↑, *NRF2↑, *HO-1↑, *GSK‐3β↓, *ROS↓, *AChE↓, *Dose↝,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

Learn↑, 1,   NeuroI↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   HO-1↑, 1,   NRF2↑, 1,   ROS↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

GSK‐3β↓, 1,  

Migration(tgid=13) ⓘ

RAGE↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 1,   BACE/β-secretase↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 1,  

Clinical Biomarkers(tgid=22) ⓘ

RAGE↓, 1,  

Functional Outcomes(tgid=23) ⓘ

memory↑, 1,   neuroP↑, 1,  
Total Targets: 15

Scientific Paper Hit Count for: GSK‐3β, Glycogen synthase kinase (GSK)3β
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:465  Target#:385  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page